allodynia glp-1 Advances in receptor agonists for pain treatment and their future potential | The Journal of Headache and Pain Benefit-Risk Assessment of GLP-1 Receptor
Description
I gained nearly 40 pounds while on the weight loss drugs and ultimately stopped taking them altogether in May
A., Roell, W
CRediT author statement The concept of the submission was by James A
Conclusion The SELECT study strengthens the view of GLP-1 medications as more than weight-loss aids
(2013) 304:H106076
Findings from the ATTAIN Phase III clinical trial programme investigating orforglipron as a tool for weight management will be shared later in 2025
